|
|
|
|
|
|
|
Onconova Therapeutics Inc. (ONTX)
|
|
5.95 0.09 (1.54%)
|
10-19 16:00
|
|
Open:
|
5.91
|
Pre. Close:
|
5.86
|
|
High:
|
5.99
|
Low:
|
5.75
|
|
Volume:
|
110,897
|
Market Cap:
|
34M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
5.993 - 6.023
|
6.023 - 6.052
|
|
Low:
|
5.682 - 5.712
|
5.712 - 5.742
|
|
Close:
|
5.901 - 5.949
|
5.949 - 5.999
|
|
|
|
Technical analysis (as of: 2018-10-19 4:37:58 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 10.52 One year: 13.05
|
|
Support:
|
Support1: 5.51 Support2: 4.58
|
|
Resistance:
|
Resistance1:
9.01 Resistance2: 11.17
|
|
Pivot:
|
6.14 
|
|
Moving Averages:
|
MA(5): 6.02 MA(20): 6.49
MA(100): 6.85 MA(250): 13.47
|
|
MACD:
|
MACD(12,26):
-0.28 Signal(12,26,9): -0.24
|
|
%K %D:
|
%K(14,3): 21.42 %D(3): 17.90
|
|
RSI:
|
RSI(14): 41.87
|
|
52-Week:
|
High: 40.05
Low: 4.95 Change(%): -83.1
|
|
Average Vol(K):
|
3-Month: 13194
10-Days 11892
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ONTX has closed above bottom band by 36.1%. Bollinger Bands are 37.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-08-14T12:49:03-04:00
Onconova Therapeutics, Inc. (ONTX) CEO Ramesh Kumar on Q2 2018 Results - Earnings Call Transcript
2018-08-14T09:06:22-04:00
Onconova Therapeutics Q2 revenues up 67%; shares up 5% premarket
2018-08-14T08:03:13-04:00
Onconova Therapeutics beats by $0.01, beats on revenue
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
